Caterina Lapenta

Title: Caterina Lapenta: Innovator in Dendritic Cell Research

Introduction

Caterina Lapenta is a prominent inventor based in Florence, Italy. She has made significant contributions to the field of immunology, particularly in the development of methods for generating highly active human dendritic cells. Her innovative work has the potential to enhance therapeutic and prophylactic vaccination strategies for both animals and humans.

Latest Patents

Caterina Lapenta holds a patent for a method that involves generating dendritic cells from peripheral blood mononuclear cells. The patent, titled "Method for generating highly active human dendritic cells from peripheral blood mononuclear cells," describes a process that includes the step of contacting type I IFN with mononuclear cells. This method allows for the derivation of dendritic cells suitable as cellular adjuvants in vaccination, achieved through a single-step treatment in a brief period of time. The invention also encompasses pharmaceutical compositions, including vaccines that utilize these cells as active principles, as well as methods for treating pathologies associated with antigens in humans.

Career Highlights

Caterina Lapenta is affiliated with the Istituto Superiore di Sanità, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to enhancing immune responses through dendritic cell manipulation.

Collaborations

Caterina collaborates with esteemed colleagues such as Mariantonia Logozzi and Stefano Maria Santini, contributing to a dynamic research environment focused on advancing immunological therapies.

Conclusion

Caterina Lapenta's contributions to dendritic cell research exemplify the impact of innovative thinking in the field of immunology. Her patented methods hold promise for improving vaccination strategies and advancing therapeutic options for various diseases.